PortfoliosLab logoPortfoliosLab logo
SIDU vs. AYTU
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

SIDU vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sidus Space, Inc. (SIDU) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SIDU vs. AYTU - Yearly Performance Comparison


2026 (YTD)20252024202320222021
SIDU
Sidus Space, Inc.
-33.12%-35.92%-44.38%-91.92%-89.64%-13.70%
AYTU
Aytu BioPharma, Inc.
1.54%52.94%-40.14%-24.87%-86.00%-19.16%

Fundamentals

Market Cap

SIDU:

$51.97M

AYTU:

$26.50M

EPS

SIDU:

-$1.30

AYTU:

-$2.02

PS Ratio

SIDU:

26.78

AYTU:

0.51

PB Ratio

SIDU:

1.03

AYTU:

1.87

Total Revenue (TTM)

SIDU:

$1.78M

AYTU:

$62.64M

Gross Profit (TTM)

SIDU:

-$5.69M

AYTU:

$41.34M

EBITDA (TTM)

SIDU:

-$28.01M

AYTU:

-$17.24M

Returns By Period

In the year-to-date period, SIDU achieves a -33.12% return, which is significantly lower than AYTU's 1.54% return.


SIDU

1D
-9.48%
1M
3.45%
YTD
-33.12%
6M
92.66%
1Y
47.89%
3Y*
-66.35%
5Y*
10Y*

AYTU

1D
-3.30%
1M
-0.00%
YTD
1.54%
6M
41.18%
1Y
127.59%
3Y*
5.63%
5Y*
-55.49%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SIDU vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SIDU
SIDU Risk / Return Rank: 6262
Overall Rank
SIDU Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
SIDU Sortino Ratio Rank: 7676
Sortino Ratio Rank
SIDU Omega Ratio Rank: 7474
Omega Ratio Rank
SIDU Calmar Ratio Rank: 5555
Calmar Ratio Rank
SIDU Martin Ratio Rank: 5353
Martin Ratio Rank

AYTU
AYTU Risk / Return Rank: 8585
Overall Rank
AYTU Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 9191
Sortino Ratio Rank
AYTU Omega Ratio Rank: 8989
Omega Ratio Rank
AYTU Calmar Ratio Rank: 8484
Calmar Ratio Rank
AYTU Martin Ratio Rank: 8484
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SIDU vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sidus Space, Inc. (SIDU) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SIDUAYTUDifference

Sharpe ratio

Return per unit of total volatility

0.28

1.09

-0.81

Sortino ratio

Return per unit of downside risk

1.90

3.01

-1.11

Omega ratio

Gain probability vs. loss probability

1.25

1.39

-0.14

Calmar ratio

Return relative to maximum drawdown

0.61

2.83

-2.22

Martin ratio

Return relative to average drawdown

1.05

7.53

-6.48

SIDU vs. AYTU - Sharpe Ratio Comparison

The current SIDU Sharpe Ratio is 0.28, which is lower than the AYTU Sharpe Ratio of 1.09. The chart below compares the historical Sharpe Ratios of SIDU and AYTU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SIDUAYTUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.28

1.09

-0.81

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.65

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.34

-0.36

+0.02

Correlation

The correlation between SIDU and AYTU is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

SIDU vs. AYTU - Dividend Comparison

Neither SIDU nor AYTU has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SIDU vs. AYTU - Drawdown Comparison

The maximum SIDU drawdown since its inception was -99.95%, roughly equal to the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for SIDU and AYTU.


Loading graphics...

Drawdown Indicators


SIDUAYTUDifference

Max Drawdown

Largest peak-to-trough decline

-99.95%

-100.00%

+0.05%

Max Drawdown (1Y)

Largest decline over 1 year

-69.05%

-42.47%

-26.58%

Max Drawdown (5Y)

Largest decline over 5 years

-99.34%

Current Drawdown

Current decline from peak

-99.83%

-100.00%

+0.17%

Average Drawdown

Average peak-to-trough decline

-91.40%

-95.05%

+3.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

39.73%

15.93%

+23.80%

Volatility

SIDU vs. AYTU - Volatility Comparison

Sidus Space, Inc. (SIDU) has a higher volatility of 37.31% compared to Aytu BioPharma, Inc. (AYTU) at 10.33%. This indicates that SIDU's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SIDUAYTUDifference

Volatility (1M)

Calculated over the trailing 1-month period

37.31%

10.33%

+26.98%

Volatility (6M)

Calculated over the trailing 6-month period

137.49%

38.47%

+99.02%

Volatility (1Y)

Calculated over the trailing 1-year period

173.88%

117.92%

+55.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

230.11%

85.84%

+144.27%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

230.11%

190.00%

+40.11%

Financials

SIDU vs. AYTU - Financials Comparison

This section allows you to compare key financial metrics between Sidus Space, Inc. and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
-1.02M
15.17M
(SIDU) Total Revenue
(AYTU) Total Revenue
Values in USD except per share items